Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers
2007 · Clinical Cancer Research · 379 citations
https://doi.org/10.1158/1078-0432.ccr-07-0869